Skip to main content

A Phase 1/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of VT-464 in Patients with Advanced Breast Cancer.

Research Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Innocrin Pharmaceutical, Inc.

Start Date

August 26, 2016

End Date

August 27, 2019
 

Administered By

Duke Cancer Institute

Awarded By

Innocrin Pharmaceutical, Inc.

Start Date

August 26, 2016

End Date

August 27, 2019